Age- and Sex-Specific Reference Intervals for Renin and Aldosterone in Healthy Individuals in Yunnan Province, China

Author:

Zhang Caiyan1,Guo ZihongORCID,Yi Chunxiu,Zhang Wen,Wang Han,Zhao Yajing1

Affiliation:

1. Fuwai Yunnan Hospital

Abstract

Abstract

Background The Renin-Angiotensin-Aldosterone System (RAAS) is crucial involvement in both diagnostic and therapeutic strategies for hypertension. However, the thresholds for detection vary depending on the characteristics of the examined population. Numerous factors can influence the quantification of the PRC and PAC, including instrumentation, methodology, geographical location, ethnicity, body posture, dietary habits, sex, and age. This study aimed to establish age- and sex-specific reference intervals for renin and aldosterone in Yunnan Province, China.Methods A cross-sectional survey was conducted using a comprehensive dataset including age, sex, medical and medication history, family history, anthropometric measurements (height, weight, blood pressure, and heart rate), blood biochemical indices, plasma renin concentrations (PRC) and plasma aldosterone concentrations (PAC). A rigorous statistical analysis was conducted to investigate variations in renin and aldosterone levels by sex and age, facilitating the redefinition of groups. Subsequently, reference intervals for renin and aldosterone were established in the defined groups.Results This study involved 5200 ostensibly healthy individuals. Renin and aldosterone levels differed significantly across sex and age groups. Specifically, PRC was significantly lower in women than men, while PAC was significantly higher in men than women. PRC decreased with age, while PAC levels were lowest in the18–24 age group and peaked in the 25–64 age group.Conclusions Our findings underscore the crucial role of sex and age when precisely evaluating renin and aldosterone levels. This groundbreaking study established for the first time age- and sex-specific reference intervals for renin and aldosterone in healthy individuals in Yunnan Province, China.

Publisher

Research Square Platform LLC

Reference22 articles.

1. Chinese Society of Cardiology, Chinese Medical Doctor Association Hypertension Committee, Hypertension Branch of China International Exchange, Medical PAf, Health Care HBoCGMA. 2018 Chinese guidelines for the management of hypertension;Writing Group of Chinese Guidelines for the Management of Hypertension CHL;Chin J Cardiovasc Med,2019

2. Blood pressure lowering for prevention of cardiovascular disease and death: a systematic review and meta-analysis;Ettehad D;Lancet,2016

3. Genetics, prevalence, screening and confirmation of primary aldosteronism: a position statement and consensus of the Working Group on Endocrine Hypertension of The European Society of Hypertension;Mulatero P;J Hypertens,2020

4. The Management of Primary Aldosteronism: Case Detection, Diagnosis, and Treatment: An Endocrine Society Clinical Practice Guideline;Funder JW;J Clin Endocrinol Metab,2016

5. Serum aldosterone effect on left ventricular structure and diastolic function in essential hypertension;Al-Hashedi EM;J Clin Hypertens (Greenwich),2023

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3